Cargando…

Combination of pembrolizumab and imatinib in a patient with double KIT mutant melanoma: A case report

RATIONALE: The treatment of metastatic melanoma has been revolutionized in the past decade because of the development of immunotherapies and targeted therapies. Despite these developments, there is still an unmet clinical need for more advanced combination therapies for the subset of patients who re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdou, Yara, Kapoor, Ankita, Hamad, Lamya, Ernstoff, Marc S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946408/ https://www.ncbi.nlm.nih.gov/pubmed/31689840 http://dx.doi.org/10.1097/MD.0000000000017769

Ejemplares similares

Imatinib mesylate in combination with pembrolizumab in patients with advanced KIT-mutant melanoma following progression on standard therapy: A phase I/II trial and study protocol
por: Hirai, Ikuko, et al.
Publicado: (2021)

Response to Imatinib in a Patient with Double-mutant KIT Metastatic Penile Melanoma
por: BEAUDOUX, Olivia, et al.
Publicado: (2021)

Brain metastasis in a patient with melanoma receiving Pembrolizumab therapy: A case report and review of the literature
por: Song, Jin-cheng, et al.
Publicado: (2017)

Immunotherapy-related pneumonitis and bacterial pneumonia after the successful treatment of metastatic malignant melanoma with pembrolizumab: A case report
por: Ma, Qin, et al.
Publicado: (2021)

Cytokine release syndrome induced by pembrolizumab: A case report
por: Zhang, Xinyu, et al.
Publicado: (2022)

Drug–drug interactions with imatinib: An observational study
por: Récoché, Isabelle, et al.
Publicado: (2016)

Responses of metastatic primary fallopian tube carcinoma to pembrolizumab and nab-paclitaxel: A case report
por: Jiang, Jian, et al.
Publicado: (2020)

Primary leptomeningeal melanomatosis successfully treated with PD-1 inhibitor pembrolizumab: A case report
por: Misir Krpan, Ana, et al.
Publicado: (2020)

A case report of a patient with inoperable primary diffuse leptomeningeal melanomatosis treated with whole-brain radiotherapy and pembrolizumab
por: Palacka, Patrik, et al.
Publicado: (2022)

A case of bronchial asthma as an immune-related adverse event of pembrolizumab treatment for bladder cancer: A case report
por: Hamada, Kazuyuki, et al.
Publicado: (2022)

Metachronous Primary Adenocarcinoma of Lung During Adjuvant Imatinib Mesylate Therapy for Gastrointestinal Stromal Tumor of Stomach: A Case Report
por: Jiang, Meng-jie, et al.
Publicado: (2015)

Platinum-doublet chemotherapy followed by pembrolizumab therapy for lung cancer with lymphangitis carcinomatosa mimicking interstitial pneumonitis: A case report
por: Yamasaki, Masahiro, et al.
Publicado: (2019)

Target Therapy of Unresectable or Metastatic Dermatofibrosarcoma Protuberans With Imatinib Mesylate: An Analysis on 22 Chinese Patients
por: Wang, Chunmeng, et al.
Publicado: (2015)

The role of c-kit and imatinib mesylate in uveal melanoma
por: Pereira, Patricia Rusa, et al.
Publicado: (2005)

Feasibility and Timing of Cytoreduction Surgery in Advanced (Metastatic or Recurrent) Gastrointestinal Stromal Tumors During the Era of Imatinib
por: Chang, Shih-Chun, et al.
Publicado: (2016)

A lung squamous cell carcinoma-associated membranous nephropathy patient free of tumor and membranous nephropathy after the treatment of surgery and radiochemotherapy following pembrolizumab: A rare case report
por: Chen, Feifei, et al.
Publicado: (2023)

Primary cerebral malignant melanoma: A case report with literature review
por: Tang, Kai, et al.
Publicado: (2017)

Meta-Analysis of the Safety and Efficacy of Interferon Combined With Dacarbazine Versus Dacarbazine Alone in Cutaneous Malignant Melanoma
por: Xin, Yong, et al.
Publicado: (2016)

Whole Cell Therapeutic Vaccine Modified With Hyper-IL6 for Combinational Treatment of Nonresected Advanced Melanoma
por: Jacek, Mackiewicz, et al.
Publicado: (2015)

Pembrolizumab versus paclitaxel for previously treated, advanced gastro-esophageal junction cancer: A systematic review and meta-analysis of randomized clinical trials
por: Swed, Sarya, et al.
Publicado: (2022)

Epidermal growth factor receptor-mutant pulmonary adenocarcinoma coexisting with tuberculosis: A case report
por: Liu, Ning, et al.
Publicado: (2021)

GNA11 Mutation in a Patient With Cutaneous Origin Melanoma: A Case Report
por: Patel, Sapna P., et al.
Publicado: (2016)

The clinical features, treatment, and prognosis of primary mediastinal malignant melanoma: A case report
por: Li, ZiHai, et al.
Publicado: (2017)

Not only for melanoma. Subcutaneous pseudoprogression in lung squamous-cell carcinoma treated with nivolumab: A case report
por: Sarfaty, Michal, et al.
Publicado: (2017)

Endobronchial melanoma metastasis 40 years after the excision of the primary cutaneous tumor: A case report
por: Karpathiou, Georgia, et al.
Publicado: (2017)

Small-cell lung cancer transformation from EGFR-mutant adenocarcinoma after EGFR-TKIs resistance: A case report
por: Jiang, Yiqian, et al.
Publicado: (2021)

Resistance to Vemurafenib Can Be Reversible After Treatment Interruption: A Case Report of a Metastatic Melanoma Patient
por: Mackiewicz-Wysocka, Małgorzata, et al.
Publicado: (2014)

Leukocyte Count Restoration Under Dabrafenib Treatment in a Melanoma Patient With Vemurafenib-Induced Leukopenia: Case Report
por: Orouji, Elias, et al.
Publicado: (2014)

A case report of immune-mediated arthritis in a patient with cutaneous melanoma receiving checkpoint inhibition therapy
por: Papaxoinis, George, et al.
Publicado: (2020)

Metastatic malignant melanoma from anorectum presenting as an isolated breast tumor: A case report and literature review
por: Yi, Xiaokang, et al.
Publicado: (2022)

Clinical responses observed with imatinib or sorafenib in melanoma patients expressing mutations in KIT
por: Handolias, D, et al.
Publicado: (2010)

Characteristics and prognosis of primary malignant melanoma of the esophagus
por: Chen, Hengchi, et al.
Publicado: (2020)

Bi-cytopenia possibly induced by anti-PD-1 antibody for primary malignant melanoma of the esophagus: A case report
por: Inadomi, Kyoko, et al.
Publicado: (2016)

A long-term survivor with esophageal melanoma and pulmonary metastasis after single-stage esophagectomy and lobectomy: Case report and literature review
por: Zhao, Tian, et al.
Publicado: (2017)

Case report: Streptomycin combined with dacronin in painless magnifying endoscopy
por: Zhou, Zheng
Publicado: (2023)

Metachronous double primary cancer of epithelial and mesenchymal origins: A case report of a rare clinical phenomenon
por: Wu, Hongzeng, et al.
Publicado: (2017)

Prognostic factors for postoperative survival in melanoma patients with bone metastasis
por: Wang, Yucheng, et al.
Publicado: (2021)

Efficacy and safety of anti-PD-1 and anti-PD-1 combined with anti-CTLA-4 immunotherapy to advanced melanoma: A systematic review and meta-analysis of randomized controlled trials
por: Hao, Chunyan, et al.
Publicado: (2017)

Apatinib combined with temozolomide treatment for pseudoprogression in glioblastoma: A case report
por: Zhao, Mingming, et al.
Publicado: (2022)

Systemic immune-inflammation index predicts prognosis in patients with different EGFR-mutant lung adenocarcinoma
por: Ju, Qing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r6isfd5a2ogmpckd7jbn47deq2